Evidence map›Paper›PMID 41230433›Full record

ArticleFrontiers in big data2025

Finding the needle in the haystack-An interpretable sequential pattern mining method for classification problems.

Alexander Grote, Anuja Hariharan, Christof Weinhardt

Abstract read
In one paragraph

Article in Frontiers in big data, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alexander GroteInstitute for Information Systems (WIN), Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.
Anuja HariharanInstitute for Information Systems (WIN), Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.
Christof WeinhardtInstitute for Information Systems (WIN), Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The analysis of discrete sequential data, such as event logs and customer clickstreams, is often challenged by the vast number of possible sequential patterns. This complexity makes it difficult to identify meaningful sequences and derive actionable insights. Methods: We propose a novel feature selection algorithm, that integrates unsupervised sequential pattern mining with supervised machine learning. Unlike existing interpretable machine learning methods, we determine important sequential patterns during the mining process, eliminating the need for post-hoc classification to assess their relevance. Compared to existing interesting measures, we introduce a local, class-specific interestingness measure that is inherently interpretable. Results: We evaluated the algorithm on three diverse datasets - churn prediction, malware sequence analysis, and a synthetic dataset - covering different sizes, application domains, and feature complexities. Our method achieved classification performance comparable to established feature selection algorithms while maintaining interpretability and reducing computational costs. Discussion: This study demonstrates a practical and efficient approach for uncovering important sequential patterns in classification tasks. By combining interpretability with competitive predictive performance, our algorithm provides practitioners with an interpretable and efficient alternative to existing methods, paving the way for new advances in sequential data analysis.

Indexed as

categorical time seriesfeature selectioninterpretable machine learningsequence classificationsequential pattern mining

Identifiers

PMID41230433
PMCPMC12604564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.